Previous 10 | Next 10 |
In a statement , the FDA says chronic shortages of certain medicines in the U.S. have not produced the expected responses from drugmakers that traditional economics predict, specifically, increasing prices to reflect a supply/demand imbalance aimed at achieving profitable production to sati...
Gainers: Direxion Natural Gas Bear 3X (NYSEARCA: GASX ) +14.6% . More news on: Direxion Daily Natural Gas Related Bear 3X Shares ETF, Direxion Daily Homebuilders & Supplies Bull 3x Shares ETF, Direxion Shares ETF Trust - Direxion Daily Pharmaceutical & Medical Bull 3X...
According to a new report from the nonprofit Institute for Clinical and Economic Review (ICER), AbbVie ( ABBV -0.6% ) and Roche ( OTCQX:RHHBY -1.6% ) were number one and two, respectively, in terms of the impact of their price increases on U.S. drug spending. More news on: AbbVie Inc...
Aprea Therapeutics (NASDAQ: APRE ) opens for trading after raising the size of its IPO to 5.67M shares from 5M and pricing its IPO at $15 , the mid‐point of the $14‐$16 expected range. More news on: Aprea Therapeutics, Monopar Therapeutics, ADC Therapeutics SA, Healthcare st...
SPDR S&P Pharmaceuticals ETF (NYSEARCA: XPH ) declares quarterly distribution of $0.0839 . More news on: SPDR S&P Pharmaceuticals ETF, , Dividend News, News on ETFs, Read more ...
(Source - Pexels/Pixbay ) It is widely believed that the Healthcare sector is a safe sector in a recessionary environment because "people always need medical treatment." While that is historically true, it seems that many investors are underweighting the substantial risks in the sector. H...
Source: nbc.com . Overview If you have followed me on Seeking Alpha for long, you have probably realized that I seldom talk about some sectors entirely: e.g., oil producers, banks, and drugmakers. While there is no doubt that all those businesses have huge market sizes and play an imp...
The Healthcare sector ranks fourth out of the 11 sectors as detailed in our Q3'19 Sector Ratings for ETFs and Mutual Funds report. Last quarter , the Healthcare sector ranked fifth. It gets our Neutral rating, which is based on an aggregation of ratings of the 322 stocks in the Healthcare...
(Source - Pexels ) Healthcare has consistently been one of the top-performing sectors on a risk-adjusted basis throughout the current bull market. During its first half, biotechnology ( IBB ) and pharmaceuticals ( XPH ) were all the rage seeing 50% annualized returns per year until the bubb...
By Stephen H. Dover, CFA, Executive Vice President, Head of Equities, Krzysztof Musialik, CFA, Research Analyst, Franklin Templeton Emerging Markets Equity, and Steve Kornfeld, CFA, Portfolio Manager, Research Analyst, Franklin Equity Group The biopharma industry has the potential to save...
News, Short Squeeze, Breakout and More Instantly...
SPDR S&P Pharmaceuticals Company Name:
XPH Stock Symbol:
NYSE Market:
Second Quarter 2024 Highlights: Record sales of $3.61 billion, up 18% in U.S. dollars and 11% organically compared to the second quarter of 2023 GAAP Diluted EPS of $0.41, up 11% compared to prior year Record Adjusted Diluted EPS of $0.44, up 22% compared to prior year ...
2024-07-19 12:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Transaction highlights: To acquire CommScope’s Outdoor Wireless Networks and Distributed Antenna Systems businesses for $2.1 billion in cash Adds advanced antenna and associated interconnect products, technologies and capabilities Complements Amphenol’s existing prod...